This site is intended for Healthcare professionals only.

Sun Pharma launches generic Welchol tablets in US


Sun Pharma launches generic Welchol tablets in US

Mumbai:  Sun Pharmaceutical Industries Ltd. announced that one of its wholly-owned subsidiaries has launched in US, the Authorized Generic (AG) version for Daiichi Sankyo Inc.’s Welchol® (colesevelam hydrochloride) 625mg tablets.

The launch is pursuant to a distribution and supply agreement between Sun Pharma’s wholly owned subsidiary and Daiichi Sankyo Inc., which grants the Sun Pharma subsidiary, exclusive rights to distribute these tablets in the US for a pre-determined period.

Welchol® Tablets recorded US sales of approximately US$ 520 million for the 12 months ending March 2018, as per IQVIA.



Source: Press Release
0 comment(s) on Sun Pharma launches generic Welchol tablets in US

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted